Stocklytics Platform
Asset logo for symbol TVTX
Travere Therapeutics
TVTX41
$13.48arrow_drop_up6.98%$0.88
Asset logo for symbol TVTX
TVTX41

$13.48

arrow_drop_up6.98%

AI Deep-Learning Forecast (TVTX)

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Travere Therapeutics (TVTX) Stocklytics Forecast

Travere Therapeutics, Inc. (TVTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for patients with rare diseases. The company has a diverse pipeline of product candidates targeting a variety of rare genetic disorders. With its strong research and development capabilities, Travere Therapeutics is poised to make significant advancements in the treatment of these diseases.
When it comes to predicting the stock price of Travere Therapeutics, Inc. (TVTX), there are several factors to consider. While past performance is not always indicative of future results, it is useful to analyze historical data and trends. Additionally, market conditions, industry developments, and company-specific news can also impact the stock price. It is important for investors to conduct thorough research and analysis before making any investment decisions.
add Travere Therapeutics to watchlist

Keep an eye on Travere Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Travere Therapeutics (TVTX) stock?

Analysts have set a target price of $20.48 for Travere Therapeutics (TVTX), based on forecasts from 27 analysts. The predicted price range extends from a high of $39 to a low of $7. This represents a potential increase of up to 189.32% and a decrease of -48.07% from the current price of $13.48. These forecasts are as of 2023 Apr 17.
help

What are the analyst ratings for Travere Therapeutics (TVTX) stock?

Currently, there are no analyst ratings available for Travere Therapeutics (TVTX), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for Travere Therapeutics (TVTX) stock?

The AI price prediction model, leveraging machine-learning techniques, forecasts that Travere Therapeutics (TVTX) stock could reach $16.3 by 2024 Sep 30. This prediction indicates a potential price change of 20.9%. The forecast has a lifetime of 30 days, culminating on the target date provided. The prediction was made on 2024 Sep 09.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media